Brady James Aloysius, a director at Verona Pharma plc ($VRNA), made one open market sale of common shares in the last 365 days, totaling about $10,800. His most recent sale occurred on August 1, 2025. These sales rank 11,256th among 11,678 individual insiders in our database, where the average sale amount is $8.6 million across about 6.4 transactions. He had no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 30, 2026 | Xeris Biopharma Holdings, Inc. | $XERS | Brady James Aloysius | Director | S | Common Stock | 10834 | $5.54 | 89,166.0000 | 177,617,307 | 10.83% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Brady James Aloysius | Director | M | Ordinary Shares | 72000 | $0.00 | 72,000.0000 | 727,223,000 | 9999.99% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Brady James Aloysius | Director | D | Ordinary Shares | 23176 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.00% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Brady James Aloysius | Director | D | Ordinary Shares | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Brady James Aloysius | Director | M | Restricted Share Unit | 72000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Brady James Aloysius | Director | D | Share Options (Right to Buy) | 288000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.04% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Brady James Aloysius | Director | D | Share Options (Right to Buy) | 96000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.01% |
| Oct. 7, 2025 | Verona Pharma plc | $VRNA | Brady James Aloysius | Director | D | Share Options (Right to Buy) | 240000 | $0.00 | 0.0000 | 727,223,000 | 100.00% | 0.03% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Brady James Aloysius | Director | M | Restricted Stock Units | 24000 | $0.00 | 72,000.0000 | 727,223,000 | 25.00% | 0.00% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Brady James Aloysius | Director | S | Ordinary Shares | 824 | $13.14 | 23,176.0000 | 727,223,000 | 3.43% | 0.00% |
| Aug. 1, 2025 | Verona Pharma plc | $VRNA | Brady James Aloysius | Director | M | Ordinary Shares | 24000 | $0.00 | 24,000.0000 | 727,223,000 | 9999.99% | 0.00% |
| April 25, 2025 | Verona Pharma plc | $VRNA | Brady James Aloysius | Director | A | Restricted Share Units | 96000 | $0.00 | 96,000.0000 | 652,311,000 | 9999.99% | 0.01% |
| March 28, 2025 | Xeris Biopharma Holdings, Inc. | $XERS | Brady James Aloysius | Director | A | Common Stock | 100000 | $0.00 | 100,000.0000 | 146,772,758 | 9999.99% | 0.07% |
| April 29, 2024 | Verona Pharma plc | $VRNA | Brady James Aloysius | Director | A | Share Options (Right to Buy) | 240000 | $0.00 | 240,000.0000 | 634,143,000 | 9999.99% | 0.04% |